PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.94%
Revenue growth above 1.5x CFLT's 4.12%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
6.95%
Gross profit growth above 1.5x CFLT's 3.03%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
11.82%
EBIT growth above 1.5x CFLT's 4.68%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
11.82%
Operating income growth above 1.5x CFLT's 4.68%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
11.87%
Positive net income growth while CFLT is negative. John Neff might see a big relative performance advantage.
10.40%
Positive EPS growth while CFLT is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
10.40%
Positive diluted EPS growth while CFLT is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.96%
Share count expansion well above CFLT's 1.62%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.96%
Diluted share count expanding well above CFLT's 1.62%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-23.46%
Negative OCF growth while CFLT is at 167.71%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-29.47%
Negative FCF growth while CFLT is at 161.02%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
32.12%
10Y revenue/share CAGR under 50% of CFLT's 244.52%. Michael Burry would suspect a lasting competitive disadvantage.
32.12%
5Y revenue/share CAGR under 50% of CFLT's 244.52%. Michael Burry would suspect a significant competitive gap or product weakness.
32.12%
3Y revenue/share CAGR under 50% of CFLT's 65.14%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
117.97%
10Y OCF/share CAGR at 75-90% of CFLT's 155.49%. Bill Ackman would demand strategic changes to close the gap in long-term cash generation.
117.97%
5Y OCF/share CAGR at 75-90% of CFLT's 155.49%. Bill Ackman would push for operational improvements to match competitor’s mid-term gains.
117.97%
3Y OCF/share CAGR at 75-90% of CFLT's 144.14%. Bill Ackman would press for improvements in margin or overhead to catch up.
29.68%
Positive 10Y CAGR while CFLT is negative. John Neff might see a substantial advantage in bottom-line trajectory.
29.68%
Positive 5Y CAGR while CFLT is negative. John Neff might view this as a strong mid-term relative advantage.
29.68%
3Y net income/share CAGR 50-75% of CFLT's 43.18%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
20.17%
AR growth well above CFLT's 20.06%. Michael Burry fears inflated revenue or higher default risk in the near future.
26.59%
Inventory growth of 26.59% while CFLT is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
4.38%
Similar asset growth to CFLT's 4.40%. Walter Schloss finds parallel expansions or investment rates.
3.42%
BV/share growth above 1.5x CFLT's 2.08%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-6.33%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
4.80%
R&D growth drastically higher vs. CFLT's 3.78%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
1.67%
We expand SG&A while CFLT cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.